Kuo Li

Kuo Li

Auto-generated profile, based on publicly available information

Kuo Li

Department of Thoracic Surgery, Huazhong University of Science and Technology Tongji Medical College Union Hospital, Wuhan, Hubei, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2024 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
PDF file
GYGuanchao Ye
Guanchao Ye
GWGuangyao Wu
Guangyao Wu
Yu QiYu Qi
Yu Qi
KLKuo Li
Kuo Li
MWMingliang Wang
Mingliang Wang
ZSZhenwei Shi
Zhenwei Shi
Objectives Although neoadjuvant immunochemotherapy has been widely applied in non-small cell lung cancer (NSCLC), predicting treatment response remains a challenge. We used pretreatment multimodal CT to explore deep learning-based immunochemotherapy response image biomarkers. Methods This study retrospectively obtained non-contrast enhanced and contrast enhancedbubu CT scans of patients with NSCLC who underwent surgery after receiving neoadjuvant immunochemotherapy at multiple centers between August 2019 and February 2023. Deep learning features were extracted from both non-contrast enhanced and contrast enhanced CT scans to construct the predictive models (LUNAI-uCT model and LUNAI-eCT model), respectively. After the feature fusion of these two types of features, a fused model (LUNAI-fCT model) was constructed. The performance of the model was evaluated using the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, positive predictive value, and negative predictive value. SHapley Additive exPlanations analysis was used to quantify the impact of CT imaging features on model prediction. To gain insights into how our model makes predictions, we employed Gradient-weighted Class Activation Mapping to generate saliency heatmaps. Results The training and validation datasets included 113 patients from Center A at the 8:2 ratio, and the test dataset included 112 patients (Center B n=73, Center C n=20, Center D n=19). In the test dataset, the LUNAI-uCT, LUNAI-eCT, and LUNAI-fCT models achieved AUCs of 0.762 (95% CI 0.654 to 0.791), 0.797 (95% CI 0.724 to 0.844), and 0.866 (95% CI 0.821 to 0.883), respectively. Conclusions By extracting deep learning features from contrast enhanced and non-contrast enhanced CT, we constructed the LUNAI-fCT model as an imaging biomarker, which can non-invasively predict pathological complete response in neoadjuvant immunochemotherapy for NSCLC.

29 March 2024 in Translational Oncology
Verified
Journal Article
Open access
GYGuanchao Ye
Guanchao Ye
CZChi Zhang
Chi Zhang
YZYuzhou Zhuang
Yuzhou Zhuang
HLHong Liu
Hong Liu
ESEnmin Song
Enmin Song
YLYongde Liao
Yongde Liao
To evaluate the effectiveness of deep learning radiomics nomogram in distinguishing the occult lymph node metastasis (OLNM) status in clinical stage IA lung adenocarcinoma. A cohort of 473 cases of lung adenocarcinomas from two hospitals was included, with 404 cases allocated to the training cohort and 69 cases to the testing cohort. Clinical characteristics and semantic features were collected, and radiomics features were extracted from the computed tomography (CT) images. Additionally, deep transfer learning (DTL) features were generated using RseNet50. Predictive models were developed using the logistic regression (LR) machine learning algorithm. Moreover, gene analysis was conducted on RNA sequencing data from 14 patients to explore the underlying biological basis of deep learning radiomics scores. The training and testing cohorts achieved AUC values of 0.826 and 0.775 for the clinical model, 0.865 and 0.801 for the radiomics model, 0.927 and 0.885 for the DTL-radiomics model, and 0.928 and 0.898 for the nomogram model. The nomogram model demonstrated superiority over the clinical model. The decision curve analysis (DCA) revealed a net benefit in predicting OLNM for all models. The investigation into the biological basis of deep learning radiomics scores identified an association between high scores and pathways related to tumor proliferation and immune cell infiltration in the microenvironment. The nomogram model, incorporating clinical-semantic features, radiomics, and DTL features, exhibited promising performance in predicting OLNM. It has the potential to provide valuable information for non-invasive lymph node staging and individualized therapeutic approaches.

13 November 2025 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
YHYu Huang
Yu Huang
BZBowen Zhao
Bowen Zhao
RYRuiyang Yan
Ruiyang Yan
CZChi Zhang
Chi Zhang
ZGZuhan Geng
Zuhan Geng
YLYongde Liao
Yongde Liao
Lung adenocarcinoma (LUAD) is one of the main causes of cancer-related mortality worldwide. Pathological risk factors such as spreading through air spaces, high-risk pathological subtypes, occult lymph nodes, and visceral pleural invasion have significant impact on patient prognosis. In recent years, there has been significant progress in the application of artificial intelligence (AI) technology, e.g., deep learning (DL), in medical image analysis and pathological diagnosis of lung cancer, offering novel approaches for predicting the aforementioned pathological risk factors. This article reviews recent advancements in AI-based analysis and prediction of pathological risk factors in lung adenocarcinoma, with a focus on the applications and limitations of DL models, focusing on studies aimed at improving diagnostic accuracy and efficiency for specific high-risk pathological subtypes. Finally, we summarize current challenges and future directions, emphasizing the need to expand dataset diversity and scale, improve model interpretability, and enhance the clinical applicability of AI models. This article aims to provide a reference for future research on the analysis and prediction of pathological risk factors of LUAD and to promote the development and application of AI, especially DL, in this field.

27 January 2026 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Open access
ZGZuhan Geng
Zuhan Geng
YHYihong Hu
Yihong Hu
SZShunchen Zhou
Shunchen Zhou
GWGuangyao Wu
Guangyao Wu
ZGZhenyu Gong
Zhenyu Gong
YLYongde Liao
Yongde Liao
Neoadjuvant immunochemotherapy (NAIC) induces tumor microenvironment remodeling in non-small cell lung cancer (NSCLC), presenting challenges for treatment response assessment. This study developed and validated a habitat radiomics approach for non-invasive prediction of tumor-infiltrating lymphocyte (TIL) status to evaluate NAIC response in NSCLC. This retrospective study enrolled 238 NSCLC patients following NAIC for clinical analysis, of which 201 patients met criteria for radiomics analysis. Patients were classified into TIL-positive and TIL-negative groups based on pathological assessment. Post-treatment computed tomography (CT) images were analyzed using K-means clustering to identify tumor habitat sub-regions for radiomic feature extraction. Seven machine learning algorithms were evaluated for TIL status prediction. Model interpretability was assessed through SHapley Additive exPlanations (SHAP) analysis. Single-cell RNA sequencing (scRNA-seq) data were analyzed to compare major pathological response (MPR) and non-MPR tumor microenvironments through cell type annotation, differentiation trajectory analysis, and intercellular communication network analysis. Pre-treatment neutrophil-to-lymphocyte ratio (NLR) showed association with pathological response in multivariable analysis. The radiomics cohort was randomly divided 7:3 into training (n = 140) and test (n = 61) sets. The Random Forest model achieved an area under the receiver operating characteristic curve (AUC) of 0.823 (95% CI: 0.694-0.932) in the test set, and the habitat radiomics model stratified patients into high and low recurrence risk groups. Single-cell analysis identified immunosuppressive features in non-responding tumors, characterized by expansion of SERPINB9 + regulatory T cells (Tregs) that regulated suppressive intercellular communication networks. This study establishes a habitat radiomics model for non-invasive assessment of TIL status following neoadjuvant immunochemotherapy in NSCLC. The model shows reliable predictive performance and prognostic stratification capability, offering potential clinical utility for treatment response evaluation and patient selection.

1 November 2020 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
YMYunchong Meng
Yunchong Meng
HXHan Xiao
Han Xiao
ZZZheng Zhang
Zheng Zhang
KLKuo Li
Kuo Li
QHQuanfu Huang
Quanfu Huang
YLYongde Liao
Yongde Liao
Situs inversus totalis (SIT) is a rare congenital condition, which is characterized by abnormal placement of the thoracic and abdominal organs. The incidence of this condition is estimated to be from 1/8000 to 1/25,000. There have been minimal reports on SIT patients with esophageal cancer. In this report, we discuss a patient with SIT complicated by middle and lower esophageal cancer who underwent laparoscopic and thoracoscopic esophagectomy with intrathoracic anastomosis, and provide useful information with regards to treatment of this rare condition.